vs
好事达（ALL）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
好事达的季度营收约是Royalty Pharma plc的1.5倍（$922.0M vs $622.0M），好事达净利率更高（266.6% vs 34.4%，领先232.2%），好事达同比增速更快（7.2% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -75.8%）
好事达集团是面向美国、加拿大市场的综合性保险服务商，提供财产险、意外险及其他保险产品。旗下设好事达保险、保障服务、健康福利、到期财产责任险四大板块，主营私人乘用车险、房屋保险，亦覆盖摩托车、房车、越野车等特种车险及各类个人保险产品。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
ALL vs RPRX — 直观对比
营收规模更大
ALL
是对方的1.5倍
$622.0M
营收增速更快
ALL
高出2.4%
4.8%
净利率更高
ALL
高出232.2%
34.4%
两年增速更快
RPRX
近两年复合增速
-75.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $922.0M | $622.0M |
| 净利润 | $2.5B | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | -1400.3% | 62.4% |
| 净利率 | 266.6% | 34.4% |
| 营收同比 | 7.2% | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | $9.25 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALLRPRX
| Q1 26 | $922.0M | — | ||
| Q4 25 | $17.3B | $622.0M | ||
| Q3 25 | $17.3B | $609.3M | ||
| Q2 25 | $16.6B | $578.7M | ||
| Q1 25 | $16.5B | $568.2M | ||
| Q4 24 | $16.5B | $593.6M | ||
| Q3 24 | $16.6B | $564.7M | ||
| Q2 24 | $15.7B | $537.3M |
净利润ALLRPRX
| Q1 26 | $2.5B | — | ||
| Q4 25 | $3.8B | $214.2M | ||
| Q3 25 | $3.7B | $288.2M | ||
| Q2 25 | $2.1B | $30.2M | ||
| Q1 25 | $595.0M | $238.3M | ||
| Q4 24 | $1.9B | $208.2M | ||
| Q3 24 | $1.2B | $544.0M | ||
| Q2 24 | $331.0M | $102.0M |
营业利润率ALLRPRX
| Q1 26 | -1400.3% | — | ||
| Q4 25 | — | 62.4% | ||
| Q3 25 | — | 70.1% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 50.2% |
净利率ALLRPRX
| Q1 26 | 266.6% | — | ||
| Q4 25 | 22.1% | 34.4% | ||
| Q3 25 | 21.7% | 47.3% | ||
| Q2 25 | 12.7% | 5.2% | ||
| Q1 25 | 3.6% | 41.9% | ||
| Q4 24 | 11.7% | 35.1% | ||
| Q3 24 | 7.2% | 96.3% | ||
| Q2 24 | 2.1% | 19.0% |
每股收益（稀释后）ALLRPRX
| Q1 26 | $9.25 | — | ||
| Q4 25 | $14.24 | $0.49 | ||
| Q3 25 | $13.95 | $0.67 | ||
| Q2 25 | $7.76 | $0.07 | ||
| Q1 25 | $2.11 | $0.55 | ||
| Q4 24 | $7.07 | $0.46 | ||
| Q3 24 | $4.33 | $1.21 | ||
| Q2 24 | $1.13 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $31.6B | $9.7B |
| 总资产 | $124.0B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ALLRPRX
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $618.7M | ||
| Q3 25 | $8.7B | $938.9M | ||
| Q2 25 | $9.6B | $631.9M | ||
| Q1 25 | $6.5B | $1.1B | ||
| Q4 24 | $4.5B | $929.0M | ||
| Q3 24 | $7.0B | $950.1M | ||
| Q2 24 | $5.3B | $1.8B |
总债务ALLRPRX
| Q1 26 | — | — | ||
| Q4 25 | $7.5B | $9.0B | ||
| Q3 25 | $8.1B | $8.9B | ||
| Q2 25 | $8.1B | $8.0B | ||
| Q1 25 | $8.1B | $7.6B | ||
| Q4 24 | $8.1B | $7.6B | ||
| Q3 24 | $8.1B | $7.6B | ||
| Q2 24 | $8.1B | $7.6B |
股东权益ALLRPRX
| Q1 26 | $31.6B | — | ||
| Q4 25 | $30.6B | $9.7B | ||
| Q3 25 | $27.5B | $9.6B | ||
| Q2 25 | $24.0B | $9.5B | ||
| Q1 25 | $22.1B | $9.8B | ||
| Q4 24 | $21.4B | $10.3B | ||
| Q3 24 | $20.9B | $10.3B | ||
| Q2 24 | $18.6B | $9.8B |
总资产ALLRPRX
| Q1 26 | $124.0B | — | ||
| Q4 25 | $119.8B | $19.6B | ||
| Q3 25 | $120.4B | $19.3B | ||
| Q2 25 | $115.9B | $18.3B | ||
| Q1 25 | $115.2B | $17.6B | ||
| Q4 24 | $111.6B | $18.2B | ||
| Q3 24 | $113.7B | $18.0B | ||
| Q2 24 | $108.4B | $17.7B |
负债/权益比ALLRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.24× | 0.92× | ||
| Q3 25 | 0.29× | 0.93× | ||
| Q2 25 | 0.34× | 0.84× | ||
| Q1 25 | 0.37× | 0.78× | ||
| Q4 24 | 0.38× | 0.74× | ||
| Q3 24 | 0.39× | 0.74× | ||
| Q2 24 | 0.43× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ALLRPRX
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $827.1M | ||
| Q3 25 | $3.3B | $702.6M | ||
| Q2 25 | $1.9B | $364.0M | ||
| Q1 25 | $2.0B | $596.1M | ||
| Q4 24 | $1.7B | $742.5M | ||
| Q3 24 | $3.2B | $703.6M | ||
| Q2 24 | $2.4B | $658.2M |
自由现金流ALLRPRX
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | — | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $2.3B | — |
自由现金流率ALLRPRX
| Q1 26 | — | — | ||
| Q4 25 | 16.7% | — | ||
| Q3 25 | 18.8% | — | ||
| Q2 25 | 11.3% | — | ||
| Q1 25 | 11.4% | — | ||
| Q4 24 | 10.0% | — | ||
| Q3 24 | 18.9% | — | ||
| Q2 24 | 14.7% | — |
资本支出强度ALLRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.4% | — |
现金转化率ALLRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.78× | 3.86× | ||
| Q3 25 | 0.88× | 2.44× | ||
| Q2 25 | 0.89× | 12.06× | ||
| Q1 25 | 3.30× | 2.50× | ||
| Q4 24 | 0.88× | 3.57× | ||
| Q3 24 | 2.69× | 1.29× | ||
| Q2 24 | 7.13× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALL
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
